[1] Kirker-Head CA.Potential applications and delivery strategies for bone morphogenetic proteins.Adv Drug DelivRev.2000;43:65.[2] Lee FY, Storer S, Hazan EJ,et al.Repair of bone allograft fracture using bone morphogenetic protein-2.Clin Orthop. 2002;397:119.[3] Balasundaram G,Yao C, Webster TJ.TiO(2) nanotubes functionalized with regions of bone morphogenetic protein-2 increases osteoblast adhesion.J Biomed Mater Res A.2008; 84:447.[4] P.ten Dijke.Bone morphogenetic protein signal transduction in bone.Current Medical Research and Opinion.2006;22(1):7- 11.[5] 蔡林鸿,杨述华.BMP-2在股骨头坏死中的研究进展[J].中国骨与关节损伤杂志,2010,25(10):958-959.[6] Bessa PC, Pedro AJ, Kl sch B,et al.Osteoinduction in human fat-derived stem cells by recombinant human bone morphogenetic protein-2 produced inEscherichia coli. Biotechnol Lett.2008;30:15.[7] 田璐鸣, 王稚英.重组人骨形态发生蛋白2在下颌骨牵引成骨过程中的作用[J].中国组织工程研究与临床康复, 2010,14(15): 2671-2674.[8] 张道永,杨爽,吕权军,等.重组人骨形态发生蛋白2在CHO细胞中的表达、鉴定及活性分析[J].生物工程学报,2006,22:968.[9] Meleady P,Henry M,Gammell P,et al.Proteomic profilingof CHO cells withenhanced rhBMP-2 productivity followingco-expression of PACEsol.Proteomics.2008;8:2611.[10] 张宏斌,武婕,詹纯列,等.重组人BMP-2生物活性的鉴定[J].药物生物技术,2009,16(2):123-126.[11] Nordsletten L. Recent developments in the use of bone morphogenetic protein in orthopaedic trauma surgery. Curr Med Res Opin.2006;22(Suppl 1):S13–S17 S23 [12] Termaat MF,Den Boer FC,Bakker FC,et al.Bone morphogenetic proteins. Development and clinical efficacy in the treatment of fractures and bone defects.J Bone Joint Surg Am.2005;87(6):1367-1378.[13] Asamura S, Mochizuki Y, Yamamoto M, et al. Bone regeneration using a bone morphogenetic protein-2 saturated slow-release gelatin hydrogel sheet: evaluation in a canine orbital floor fracture model.Ann Plast Surg.2010;64(4): 496-502.[14] 王丁丁, 曾戎,杨敏儿,等.缓释型重组人骨形态发生蛋白2/壳聚糖生物骨修复材料诱导骨形成[J].中国组织工程研究与临床康复,2011,15(25):4583-4586.[15] 周薇娜,杜一飞, 武和明,等.透明质酸钠复合rhBMP-2促进骨质疏松症种植体骨结合的实验研究[J].南京医科大学学报(自然科学版),2010,30(7):957-961.[16] Fromigue O,Hamidouche Z,Chateauvieux S,et al.Distinct osteoblastic differentiation potential of murine fetal liver and bone marrow stroma-derived. mesenchymal stem cells.J Cell Biochem.2008;104(2):620-628.[17] 李轶,冉炜,刘满珍,等.新型骨组织工程支架复合重组人骨形态发生蛋白-2修复兔下颌骨缺损的实验研究[J].生物医学工程学杂志,2010,27(4):825-828.[18] 计艳,胡勤刚,童昕,等.新型种植体涂层材料rhBMP-2/PDLLA诱导成骨作用的观察[J].口腔医学研究,2009,25(1):4-7.[19] 孟纯阳,蒋电明,安洪,等.多孔n-HA /PA66支架复合rhBMP-2修复兔桡骨缺损的实验研究[J].中国生物工程杂志,2009,29(8):8-13.[20] 余雷,刘兴炎,葛宝丰,等.多孔载因子CPC促进骨缺损愈合的实验研究[J].中国矫形外科杂志,2010,18(8):673-677.[21] 赵清桐,赖仁发,汪距,等.壳聚糖/β-磷酸三钙/重组人骨形态发生蛋白2可注射性复合体修复兔下颌骨缺损[J].中国组织工程研究与临床康复,2009,13(51):10065-10068.[22] 刘越,赵艳梅,田学忠,等.具有缓释rhBMP-2作用的仿生骨支架的构建及其体外生物活性评价[J].中国矫形外科杂志,2011,19(20): 1726-1730.[23] Herford AS, Boyne PJ. Reconstruction of mandibular continuity defects with bone morphogenetic protein-2 (rhBMP-2).J Oral Maxillofac Surg.2008;66(4):616-24.[24] Glassman SD, Carreon L, Djurasovic M, et al. Posterolateral lumbar spine fusion with INFUSE bone graft.Spine J.2007; 7(1):44-9.[25] Pengde Kang,Bin Shen,Jing Yang,et al.Repairing defect and pre-venting collapse of canine femoral head using titanium implant en-hanced by autogenous bone graft and rhBMP-2. Connective Tissue Research.2007;48(4):171-179.[26] Haidar ZS,Hamdy RC, Tabrizian M. Delivery of recombinant bone morphogenetic proteins for bone regeneration and repair. Part A: Current challenges in BMP delivery. Biotechnol Lett.2009;31(12):1817-24.[27] Axelrad TW, Einhorn TA.Bone morphogenetic proteins in orthopaedic surgery. Cytokine Growth Factor Rev.2009; 20(5-6): 481-488.[28] Lewandrowski K, Nanson C,Calderon R.Vertebral osteolysis after posterior interbody lumbar fusion with recombinant human bone morphogenetic protein2:a report of Wve cases. Spine.2007;7(5):609-614.[29] 赵刚,刘宏建, 周英杰,等.不同充填材料应用于经皮椎体成形术的效果及影像特征[J].中国组织工程研究与临床康复,2010, 14(16):3007-3010.[30] 肖荣驰,李宁宁,罗军,等.重组人骨形态发生蛋白2人工骨复合物在腰椎横突间植骨融合中的作用[J]. 中国组织工程研究与临床康复,2009,13(34):6697-6700. |